We've found
31,654
archived clinical trials in
Cardiology
We've found
31,654
archived clinical trials in
Cardiology
Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial
Updated: 1/27/2014
Prospective, Multicenter, Randomized Controlled Trial of Endovascular Aneurysm Repair Using a Bilateral Percutaneous Approach (PEVAR) vs. Standard Approach (SEVAR) Using the IntuiTrak Endovascular AAA Delivery System and the Prostar XL or Perclose ProGlide Suture-Mediated Closure System
Status: Enrolling
Updated: 1/27/2014
Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial
Updated: 1/27/2014
Prospective, Multicenter, Randomized Controlled Trial of Endovascular Aneurysm Repair Using a Bilateral Percutaneous Approach (PEVAR) vs. Standard Approach (SEVAR) Using the IntuiTrak Endovascular AAA Delivery System and the Prostar XL or Perclose ProGlide Suture-Mediated Closure System
Status: Enrolling
Updated: 1/27/2014
Click here to add this to my saved trials
Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial
Updated: 1/27/2014
Prospective, Multicenter, Randomized Controlled Trial of Endovascular Aneurysm Repair Using a Bilateral Percutaneous Approach (PEVAR) vs. Standard Approach (SEVAR) Using the IntuiTrak Endovascular AAA Delivery System and the Prostar XL or Perclose ProGlide Suture-Mediated Closure System
Status: Enrolling
Updated: 1/27/2014
Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial
Updated: 1/27/2014
Prospective, Multicenter, Randomized Controlled Trial of Endovascular Aneurysm Repair Using a Bilateral Percutaneous Approach (PEVAR) vs. Standard Approach (SEVAR) Using the IntuiTrak Endovascular AAA Delivery System and the Prostar XL or Perclose ProGlide Suture-Mediated Closure System
Status: Enrolling
Updated: 1/27/2014
Click here to add this to my saved trials
Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial
Updated: 1/27/2014
Prospective, Multicenter, Randomized Controlled Trial of Endovascular Aneurysm Repair Using a Bilateral Percutaneous Approach (PEVAR) vs. Standard Approach (SEVAR) Using the IntuiTrak Endovascular AAA Delivery System and the Prostar XL or Perclose ProGlide Suture-Mediated Closure System
Status: Enrolling
Updated: 1/27/2014
Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial
Updated: 1/27/2014
Prospective, Multicenter, Randomized Controlled Trial of Endovascular Aneurysm Repair Using a Bilateral Percutaneous Approach (PEVAR) vs. Standard Approach (SEVAR) Using the IntuiTrak Endovascular AAA Delivery System and the Prostar XL or Perclose ProGlide Suture-Mediated Closure System
Status: Enrolling
Updated: 1/27/2014
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure
Updated: 2/6/2014
A Phase I/II Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Retrograde Delivery to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 2/6/2014
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure
Updated: 2/6/2014
A Phase I/II Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Retrograde Delivery to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 2/6/2014
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure
Updated: 2/6/2014
A Phase I/II Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Retrograde Delivery to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 2/6/2014
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure
Updated: 2/6/2014
A Phase I/II Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Retrograde Delivery to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 2/6/2014
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure
Updated: 2/6/2014
A Phase I/II Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Retrograde Delivery to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 2/6/2014
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure
Updated: 2/6/2014
A Phase I/II Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Retrograde Delivery to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 2/6/2014
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure
Updated: 2/6/2014
A Phase I/II Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Retrograde Delivery to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 2/6/2014
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure
Updated: 2/6/2014
A Phase I/II Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Retrograde Delivery to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 2/6/2014
Click here to add this to my saved trials
Developing a "Hub and Satellite" Heart Failure Provider's Network: A New Model of Community Based Outpatient Clinic (CBOC) Providers Study
Updated: 2/6/2014
Developing a Hub and Satellite Heart Failure Providers Network
Status: Enrolling
Updated: 2/6/2014
Developing a "Hub and Satellite" Heart Failure Provider's Network: A New Model of Community Based Outpatient Clinic (CBOC) Providers Study
Updated: 2/6/2014
Developing a Hub and Satellite Heart Failure Providers Network
Status: Enrolling
Updated: 2/6/2014
Click here to add this to my saved trials
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Updated: 2/7/2014
Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide)
Status: Enrolling
Updated: 2/7/2014
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Updated: 2/7/2014
Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide)
Status: Enrolling
Updated: 2/7/2014
Click here to add this to my saved trials
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Updated: 2/7/2014
Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide)
Status: Enrolling
Updated: 2/7/2014
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Updated: 2/7/2014
Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide)
Status: Enrolling
Updated: 2/7/2014
Click here to add this to my saved trials
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Updated: 2/7/2014
Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide)
Status: Enrolling
Updated: 2/7/2014
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Updated: 2/7/2014
Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide)
Status: Enrolling
Updated: 2/7/2014
Click here to add this to my saved trials
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Updated: 2/7/2014
Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide)
Status: Enrolling
Updated: 2/7/2014
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Updated: 2/7/2014
Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide)
Status: Enrolling
Updated: 2/7/2014
Click here to add this to my saved trials
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Updated: 2/7/2014
Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide)
Status: Enrolling
Updated: 2/7/2014
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Updated: 2/7/2014
Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide)
Status: Enrolling
Updated: 2/7/2014
Click here to add this to my saved trials
Activation Timing and Atrial Fibrillation
Updated: 2/12/2014
Proof-of-concept Study to Assess Ventricular Activation Timing During Atrial Fibrillation, or Bundle Branch Block and Sinus Rhythm
Status: Enrolling
Updated: 2/12/2014
Activation Timing and Atrial Fibrillation
Updated: 2/12/2014
Proof-of-concept Study to Assess Ventricular Activation Timing During Atrial Fibrillation, or Bundle Branch Block and Sinus Rhythm
Status: Enrolling
Updated: 2/12/2014
Click here to add this to my saved trials
Impact of Ticagrelor Re-load on Pharmacodynamic Profiles
Updated: 2/14/2014
Impact of Ticagrelor Re-load on Pharmacodynamic Profiles in Patients on Maintenance Ticagrelor Therapy
Status: Enrolling
Updated: 2/14/2014
Impact of Ticagrelor Re-load on Pharmacodynamic Profiles
Updated: 2/14/2014
Impact of Ticagrelor Re-load on Pharmacodynamic Profiles in Patients on Maintenance Ticagrelor Therapy
Status: Enrolling
Updated: 2/14/2014
Click here to add this to my saved trials
Phosphorous Magnetic Resonance Spectroscopy of Heart
Updated: 2/18/2014
31P Magnetic Resonance Spectroscopy of Heart
Status: Enrolling
Updated: 2/18/2014
Phosphorous Magnetic Resonance Spectroscopy of Heart
Updated: 2/18/2014
31P Magnetic Resonance Spectroscopy of Heart
Status: Enrolling
Updated: 2/18/2014
Click here to add this to my saved trials
Phosphorous Magnetic Resonance Spectroscopy of Heart
Updated: 2/18/2014
31P Magnetic Resonance Spectroscopy of Heart
Status: Enrolling
Updated: 2/18/2014
Phosphorous Magnetic Resonance Spectroscopy of Heart
Updated: 2/18/2014
31P Magnetic Resonance Spectroscopy of Heart
Status: Enrolling
Updated: 2/18/2014
Click here to add this to my saved trials
Effects of Epicatechin on Functional Capacity, Skeletal Muscle Structure and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction (HFPEF)
Status: Enrolling
Updated: 2/19/2014
Updated: 2/19/2014
Effects of Epicatechin on Functional Capacity, Skeletal Muscle Structure and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction (HFPEF)
Status: Enrolling
Updated: 2/19/2014
Updated: 2/19/2014
Click here to add this to my saved trials
Evaluation of Cross-Linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects
Updated: 3/3/2014
A Phase 2b, Randomized, Double-Blind, Multi-center Study Comparing Cross-linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects
Status: Enrolling
Updated: 3/3/2014
Evaluation of Cross-Linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects
Updated: 3/3/2014
A Phase 2b, Randomized, Double-Blind, Multi-center Study Comparing Cross-linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects
Status: Enrolling
Updated: 3/3/2014
Click here to add this to my saved trials
Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care
Updated: 3/4/2014
Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care
Status: Enrolling
Updated: 3/4/2014
Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care
Updated: 3/4/2014
Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care
Status: Enrolling
Updated: 3/4/2014
Click here to add this to my saved trials
Pharmacokinetics of Dexmedetomidine in Children During Cardiopulmonary Bypass (CPB)
Updated: 3/6/2014
Pharmacokinetics of Dexmedetomidine in Children During Cardiopulmonary Bypass (CPB)
Status: Enrolling
Updated: 3/6/2014
Pharmacokinetics of Dexmedetomidine in Children During Cardiopulmonary Bypass (CPB)
Updated: 3/6/2014
Pharmacokinetics of Dexmedetomidine in Children During Cardiopulmonary Bypass (CPB)
Status: Enrolling
Updated: 3/6/2014
Click here to add this to my saved trials
Aspirin and Plavix Following Coronary Artery Bypass Grafting
Updated: 3/7/2014
Aspirin and Plavix Following Coronary Artery Bypass Grafting (ASAP-CABG)
Status: Enrolling
Updated: 3/7/2014
Aspirin and Plavix Following Coronary Artery Bypass Grafting
Updated: 3/7/2014
Aspirin and Plavix Following Coronary Artery Bypass Grafting (ASAP-CABG)
Status: Enrolling
Updated: 3/7/2014
Click here to add this to my saved trials
Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy
Updated: 3/13/2014
Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy
Status: Enrolling
Updated: 3/13/2014
Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy
Updated: 3/13/2014
Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy
Status: Enrolling
Updated: 3/13/2014
Click here to add this to my saved trials
Laser Therapy Versus Electrosurgery For Nasal Telangiectasias
Updated: 3/14/2014
Evaluation of Laser Therapy Vs Electrosurgery For Nasal Telangiectasias Using A Novel Vascular Imaging Device
Status: Enrolling
Updated: 3/14/2014
Laser Therapy Versus Electrosurgery For Nasal Telangiectasias
Updated: 3/14/2014
Evaluation of Laser Therapy Vs Electrosurgery For Nasal Telangiectasias Using A Novel Vascular Imaging Device
Status: Enrolling
Updated: 3/14/2014
Click here to add this to my saved trials
A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
Updated: 3/19/2014
A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
Status: Enrolling
Updated: 3/19/2014
A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
Updated: 3/19/2014
A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
Status: Enrolling
Updated: 3/19/2014
Click here to add this to my saved trials
Adipose Derived Regenerative Cellular Therapy of Chronic Wounds
Updated: 3/19/2014
Adipose Derived Regenerative Cellular Therapy of Chronic Wounds
Status: Enrolling
Updated: 3/19/2014
Adipose Derived Regenerative Cellular Therapy of Chronic Wounds
Updated: 3/19/2014
Adipose Derived Regenerative Cellular Therapy of Chronic Wounds
Status: Enrolling
Updated: 3/19/2014
Click here to add this to my saved trials
Clinical Performance Evaluation of AQT90 FLEX BNP and NT-proBNP
Updated: 3/21/2014
Clinical Sensitivity and Specificity Study of AQT90 FLEX BNP and NT-proBNP
Status: Enrolling
Updated: 3/21/2014
Clinical Performance Evaluation of AQT90 FLEX BNP and NT-proBNP
Updated: 3/21/2014
Clinical Sensitivity and Specificity Study of AQT90 FLEX BNP and NT-proBNP
Status: Enrolling
Updated: 3/21/2014
Click here to add this to my saved trials
Verizon Wireless - Sarasota Memorial Hospital Converged Health Management (CHM) For Heart Failure
Updated: 3/31/2014
Verizon Wireless - Sarasota Memorial Hospital Converged Health Management (CHM) For Heart Failure
Status: Enrolling
Updated: 3/31/2014
Verizon Wireless - Sarasota Memorial Hospital Converged Health Management (CHM) For Heart Failure
Updated: 3/31/2014
Verizon Wireless - Sarasota Memorial Hospital Converged Health Management (CHM) For Heart Failure
Status: Enrolling
Updated: 3/31/2014
Click here to add this to my saved trials
Effect of Prasugrel Versus Clopidogrel on Platelet Function After Bivalirudin Cessation
Updated: 4/2/2014
The Effect of Prasugrel as Compared to Clopidogrel on Platelet Function Immediately Following the Termination of Intravenous Bivalirudin in Patients Undergoing Percutaneous Coronary and Structural Cardiac Intervention
Status: Enrolling
Updated: 4/2/2014
Effect of Prasugrel Versus Clopidogrel on Platelet Function After Bivalirudin Cessation
Updated: 4/2/2014
The Effect of Prasugrel as Compared to Clopidogrel on Platelet Function Immediately Following the Termination of Intravenous Bivalirudin in Patients Undergoing Percutaneous Coronary and Structural Cardiac Intervention
Status: Enrolling
Updated: 4/2/2014
Click here to add this to my saved trials
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Updated: 4/3/2014
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated: 4/3/2014
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Updated: 4/3/2014
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated: 4/3/2014
Click here to add this to my saved trials
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Updated: 4/3/2014
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated: 4/3/2014
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Updated: 4/3/2014
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated: 4/3/2014
Click here to add this to my saved trials
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Updated: 4/3/2014
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated: 4/3/2014
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Updated: 4/3/2014
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated: 4/3/2014
Click here to add this to my saved trials
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Updated: 4/3/2014
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated: 4/3/2014
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Updated: 4/3/2014
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated: 4/3/2014
Click here to add this to my saved trials
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Updated: 4/3/2014
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated: 4/3/2014
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Updated: 4/3/2014
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated: 4/3/2014
Click here to add this to my saved trials
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Updated: 4/3/2014
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated: 4/3/2014
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Updated: 4/3/2014
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated: 4/3/2014
Click here to add this to my saved trials
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Updated: 4/3/2014
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated: 4/3/2014
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Updated: 4/3/2014
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated: 4/3/2014
Click here to add this to my saved trials
Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian Volunteers
Updated: 4/17/2014
A Double-center, Randomized, Double-blinded, 2-way Crossover, Placebo-controlled Study: Comparison of Single Oral Dose 400mg Moxifloxacin-induced QT Prolongation Between Healthy Chinese Volunteers and Caucasian Volunteers
Status: Enrolling
Updated: 4/17/2014
Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian Volunteers
Updated: 4/17/2014
A Double-center, Randomized, Double-blinded, 2-way Crossover, Placebo-controlled Study: Comparison of Single Oral Dose 400mg Moxifloxacin-induced QT Prolongation Between Healthy Chinese Volunteers and Caucasian Volunteers
Status: Enrolling
Updated: 4/17/2014
Click here to add this to my saved trials
Study to Improve Long Term Vein Graft Patency After Coronary Bypass Surgery by Using a Novel Endoscopic Harvesting Technique
Updated: 4/21/2014
OPTION Trial: Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques
Status: Enrolling
Updated: 4/21/2014
Study to Improve Long Term Vein Graft Patency After Coronary Bypass Surgery by Using a Novel Endoscopic Harvesting Technique
Updated: 4/21/2014
OPTION Trial: Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques
Status: Enrolling
Updated: 4/21/2014
Click here to add this to my saved trials
Study to Improve Long Term Vein Graft Patency After Coronary Bypass Surgery by Using a Novel Endoscopic Harvesting Technique
Updated: 4/21/2014
OPTION Trial: Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques
Status: Enrolling
Updated: 4/21/2014
Study to Improve Long Term Vein Graft Patency After Coronary Bypass Surgery by Using a Novel Endoscopic Harvesting Technique
Updated: 4/21/2014
OPTION Trial: Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques
Status: Enrolling
Updated: 4/21/2014
Click here to add this to my saved trials
Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard antiVEGF Dosing
Updated: 4/30/2014
Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard AntiVEGF Dosing
Status: Enrolling
Updated: 4/30/2014
Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard antiVEGF Dosing
Updated: 4/30/2014
Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard AntiVEGF Dosing
Status: Enrolling
Updated: 4/30/2014
Click here to add this to my saved trials
Measurement of D-Dimer Levels in Patients With Confirmed Deep Vein Thrombosis
Updated: 5/19/2014
Measurement of D-Dimer Levels in Patients With Confirmed Deep Vein Thrombosis
Status: Enrolling
Updated: 5/19/2014
Measurement of D-Dimer Levels in Patients With Confirmed Deep Vein Thrombosis
Updated: 5/19/2014
Measurement of D-Dimer Levels in Patients With Confirmed Deep Vein Thrombosis
Status: Enrolling
Updated: 5/19/2014
Click here to add this to my saved trials
Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients
Updated: 5/20/2014
Double-Blind, Randomized Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients
Status: Enrolling
Updated: 5/20/2014
Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients
Updated: 5/20/2014
Double-Blind, Randomized Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients
Status: Enrolling
Updated: 5/20/2014
Click here to add this to my saved trials
High Intensity Interval Exercise in Diastolic Heart Failure
Updated: 5/27/2014
High-intensity Aerobic Interval Training vs. Moderate-intensity Continuous Exercise Training in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 5/27/2014
High Intensity Interval Exercise in Diastolic Heart Failure
Updated: 5/27/2014
High-intensity Aerobic Interval Training vs. Moderate-intensity Continuous Exercise Training in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 5/27/2014
Click here to add this to my saved trials
High Intensity Interval Exercise in Diastolic Heart Failure
Updated: 5/27/2014
High-intensity Aerobic Interval Training vs. Moderate-intensity Continuous Exercise Training in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 5/27/2014
High Intensity Interval Exercise in Diastolic Heart Failure
Updated: 5/27/2014
High-intensity Aerobic Interval Training vs. Moderate-intensity Continuous Exercise Training in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 5/27/2014
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
Updated: 6/3/2014
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
Updated: 6/3/2014
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
Updated: 6/3/2014
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
Updated: 6/3/2014
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
Updated: 6/3/2014
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
Updated: 6/3/2014
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
Updated: 6/3/2014
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
Updated: 6/3/2014
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
Updated: 6/3/2014
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
Updated: 6/3/2014
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
Updated: 6/3/2014
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
Updated: 6/3/2014
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Click here to add this to my saved trials